CDC's ACIP recommends higher dose, Seqirus, Sanofi flu vaccines in adults 65 and older
Higher dose or adjuvanted seasonal flu vaccines are better for older adults, according to a CDC advisory committee’s recommendation.
The CDC’s Advisory Committee on Immunization Practices on Wednesday unanimously recommended (15-0) three flu vaccines for adults over the age of 65: Seqirus’s Fluad and Sanofi’s Fluzone and Flublok. Flublok was originally developed by Protein Sciences, which then became Sanofi’s when the Big Pharma acquired the company in 2017 for $650 million upfront and $100 million more in milestones.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
